Concepedia

R-L. Hong

RH

Statistics

Publications

3

Citations

159

H-Index

3

Active since

2021

Affiliations

National Cancer Centre Singapore(Current)

Ramathibodi Hospital

National Taiwan University Hospital

Mahidol University

Sarawak General Hospital

R-L. Hong is an author at National Cancer Centre Singapore specializing in oncology, medicine, and cancer pharmacology.

Publications per year

2021–2024

3

Publications

3

Pembrolizumab monotherapy versus chemotherapy in platinum-pretreated, recurrent or metastatic nasopharyngeal cancer (KEYNOTE-122): an open-label, randomized, phase III trial

Anthony T.�C. Chan, V.H.F. Lee, R-L. Hong et al. · Annals of Oncology · 2022 · 107 citations · Full text

, , +17

858O Results of KEYNOTE-122: A phase III study of pembrolizumab (pembro) monotherapy vs chemotherapy (chemo) for platinum-pretreated, recurrent or metastatic (R/M) nasopharyngeal carcinoma (NPC)

Anthony T.�C. Chan, Victor Lee, R-L. Hong et al. · Annals of Oncology · 2021 · 37 citations · Full text

, , +14

Gemcitabine, carboplatin, and Epstein–Barr virus-specific autologous cytotoxic T lymphocytes for recurrent or metastatic nasopharyngeal carcinoma: VANCE, an international randomized phase III trial

Han Chong Toh, M-H Yang, Wang Hm et al. · Annals of Oncology · 2024 · 15 citations · Full text

, , +14

1–3 of 3